167 related articles for article (PubMed ID: 11409297)
1. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.
Evans D; de Heer J; Hagemann C; Wendt D; Wolf A; Beisiegel U; Mann WA
Exp Clin Endocrinol Diabetes; 2001; 109(3):151-4. PubMed ID: 11409297
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.
Ek J; Andersen G; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
Diabetologia; 2001 Dec; 44(12):2220-6. PubMed ID: 11793024
[TBL] [Abstract][Full Text] [Related]
3. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
[TBL] [Abstract][Full Text] [Related]
4. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
6. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.
Lei HH; Chen MH; Yang WS; Chiu MC; Chen MC; Tai TY; Chuang LM
Metabolism; 2000 Oct; 49(10):1267-70. PubMed ID: 11079814
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
Moon MK; Cho YM; Jung HS; Park YJ; Yoon KH; Sung YA; Park BL; Lee HK; Park KS; Shin HD
Diabet Med; 2005 Sep; 22(9):1161-6. PubMed ID: 16108843
[TBL] [Abstract][Full Text] [Related]
9. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
Wang C; Zhai F; Chi Y; Wang G
Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.
Lee BC; Lee HJ; Chung JH
Neurosci Lett; 2006 Dec; 410(2):141-5. PubMed ID: 17084528
[TBL] [Abstract][Full Text] [Related]
11. [Polymorphism of pro12Ala in peroxisome proliferator activated receptor gamma 2 (PPAgamma2): beta cell function and insulin sensitivity].
Fritsche A; Madaus A; Tschritter O; Ozeker M; Wulle EL; Machicao F; Häring H; Stumvoll M
Dtsch Med Wochenschr; 2001 May; 126(20):580-4. PubMed ID: 11402923
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms in the peroxisome proliferator-activated receptor gamma gene and osteoarthritis of the knee.
Cheng S; Afif H; Martel-Pelletier J; Benderdour M; Pelletier JP; Hilal G; Haraoui P; Raynauld JP; Choquette D; Fahmi H
Ann Rheum Dis; 2006 Oct; 65(10):1394-7. PubMed ID: 16973789
[TBL] [Abstract][Full Text] [Related]
13. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
Kawasaki I; Tahara H; Emoto M; Shoji T; Shioji A; Okuno Y; Inaba M; Nishizawa Y
Osaka City Med J; 2002 Jun; 48(1):23-8. PubMed ID: 12375694
[TBL] [Abstract][Full Text] [Related]
14. Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study.
Lagou V; Scott RA; Manios Y; Chen TL; Wang G; Grammatikaki E; Kortsalioudaki C; Liarigkovinos T; Moschonis G; Roma-Giannikou E; Pitsiladis YP
Obesity (Silver Spring); 2008 Apr; 16(4):913-8. PubMed ID: 18379566
[TBL] [Abstract][Full Text] [Related]
15. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
[TBL] [Abstract][Full Text] [Related]
16. The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood.
Pihlajamäki J; Vanhala M; Vanhala P; Laakso M
Obes Res; 2004 Feb; 12(2):187-90. PubMed ID: 14981210
[TBL] [Abstract][Full Text] [Related]
17. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population.
Malecki MT; Frey J; Moczulski D; Klupa T; Kozek E; Sieradzki J
Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):505-9. PubMed ID: 14714273
[TBL] [Abstract][Full Text] [Related]
19. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.
Tönjes A; Stumvoll M
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):410-4. PubMed ID: 17563457
[TBL] [Abstract][Full Text] [Related]
20. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.
Memisoglu A; Hu FB; Hankinson SE; Manson JE; De Vivo I; Willett WC; Hunter DJ
Hum Mol Genet; 2003 Nov; 12(22):2923-9. PubMed ID: 14506127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
